Attached are PDFs with data from studies demonstrating efficacy of Cerebrolysin via intranasal administration, showing greater concentration within the CNS and less binding to peripheral tissues.
From the papers:
Tissue concentrations of 125I-Cerebrolysin peptides were measured in rats by quantitative gamma counting at 35 minutes after intravenous administration of a mixture of labeled and unlabeled Cerebrolysin (average 0.79 mg [110 µL] and 35.24 µCi]) (41). Mean concentrations of 125ICerebrolysin were 4501 ng/g in blood, ranged from 170 to 224 ng/g in tissue in brain regions and from 188 to 329 ng/g in spinal cord tissue, and were much higher in peripheral organs (41). After its intranasal administration, however, Cerebrolysin concentrations were greater in CNS regions (particularly in the hippocampus, septal nucleus, frontal cortex and olfactory bulb) and lower in peripheral tissues (41).
..comparison of intravenous vs. intranasal administration of Cerebrolysin in 10 rats demonstrates greater delivery to the CNS with intranasal delivery (p0.01) and greater delivery to the peripheral organs and blood with intravenous delivery (p0.01). On average, intravenous blood concentration were 6.8 times greater than intranasal blood concentrations. Five CNS tissues were collected and counted including ventral brain dura, dorsal brain dura, optic nerve, trigeminal nerve, cervical spinal cord, olfactory epithelium, deep cervical lymph nodes and common carotid had significantly greater delivery following intranasal administration than intravenous delivery (p0.01). All peripheral tissues (except superficial lymph nodes, esophagus, and trachea) had significantly greater concentration following intravenous delivery (p0.01). Conclusions:Overall, these results demonstrate significantly greater delivery to the brain following intranasal administration of Cerebrolysin. Intranasal Cerebrolysin is directly delivered to the brain along the olfactory and trigeminal pathways. Intranasal administration of Cerebrolysin will provide a non-invasive method to treat Alzheimer’s disease and stroke patients by providing larger drug concentrations to the brain and minimal concentrations to the peripheral organs.
This should be good news to those unwilling to inject themselves over fear of needles or glass particles or formation of scar tissue. Simply dump your Cerebrolysin in a nasal spray bottle and get squirting.
Have fun!
Attached Files
Edited by cryonicsculture, 28 May 2014 - 12:23 AM.